CellAegis Devices, Inc. announces 1st Clinical Trial in EU
May 2, 2013: CellAegis Devices, Inc., announced today the first clinical trial program in the...
Search for Articles
May 2, 2013
Apr 16, 2013
VentriNova, Inc. presenting at TEDMED 2013
April 16, 2013: VentriNova, Inc., a cardiac regenerative medicine biotechnology company, announced today that Dr....
Mar 7, 2013
CellAegis Devices, Inc. Receives Marketing Authorization
March 7, 2013: CellAegis Devices, Inc., announced today that it has received marketing authorization from...
Feb 27, 2013
CellAegis Devices, Inc. receives Investigational Testing Approval from Health Canada
February 27, 2013: CellAegis Devices, Inc., announced today that it has received an Investigational Testing...
Feb 26, 2013
DecImmune Therapeutics Raises $2.25M
February 26, 2013: DecImmune Therapeutics announced today that it has completed a $2.25 million equity...
Nov 29, 2012
CardiAQ Valve Technologies Raises $37.3M Series B
Nov. 29, 2012 : CardiAQ™ Valve Technologies, Inc., a privately held medical device company developing...